Wednesday, August 3, 2022

From West to East, EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Stretching its RNG Footprint Across Canada

 

  • Formed just two years ago, EverGen began with the acquisition of two waste-to-energy facilities in British Columbia
  • In the last two months, EverGen has expanded its Canadian presence, making acquisitions of facilities and projects in Alberta and Ontario
  • The company is targeting RNG production in excess of 1 million gigajoules annually

Have garbage, will travel. That could easily be the mantra of Chase Edgelow and Mischa Zajtmann, the founders of EverGen Infrastructure (TSX.V: EVGN) (OTCQB: EVGIF), a company working on disrupting Canada’s energy industry with its renewable natural gas (“RNG”) infrastructure platform. As recently as May, EverGen described itself as being focused on its home province of British Columbia, but that is no longer the case, as the company has made important acquisitions that have taken EverGen’s organic waste-to-energy technology as far east as Ontario so far.

With RNG, different types of organic waste (e.g., food or agricultural waste) are feedstock for an anaerobic digester where it can be turned into digestate or biogas. Digestate is used for products such as fertilizer and soil amendments. The biogas is further processed with the RNG output comparable with pipeline-grade natural gas. RNG is Earth-friendly and sustainable, requiring no drilling while making meaningful use of rubbish rather than sending it to a landfill where it rots and emits greenhouse gases. 

Edgelow and Zajtmann formed EverGen in 2020 for the purpose of acquiring, developing, building, owning, and operating a portfolio of RNG and related infrastructure projects. The initial focus was B.C., where EverGen bought its first two organic waste processing facilities and began establishing relationships with utilities to purchase their RNG, which would be added to the gas grid.

For its feedstock, EverGen has contracts with municipalities and waste haulers. For its production, EverGen has fixed-price, long-term contracts to supply RNG to offtake partners, including FortisBC. 

Earlier this month, EverGen announced closing its acquisition of a 67% interest in Grow the Energy Circle Ltd., marking its entrance into the Alberta energy market. Located on the Perry Family farm outside Lethbridge, Alberta, GrowTEC is an operating farm scale biogas facility consisting of an anaerobic digester which has been converting biodegradable waste into biogas and generating renewable power for over seven years. With EverGen in the mix, the facility is undergoing some upgrades to process the biogas into RNG, which will be purchased by FortisBC as part of its goal to have a minimum of 15 percent of its gas supply carbon neutral by 2030.

The GrowTEC acquisition came six weeks after EverGen inked a deal with Northeast Renewables LP to acquire a 50% interest in a portfolio of RNG development projects in southern Ontario known as Project Radius. Project Radius is a late-development-stage portfolio of three high-quality, on-farm RNG projects, collectively capable of producing about 1.7 million gigajoules (“GJ”) annually of RNG. The three projects are expected to be constructed during 2023-2024. Feedstock supply and offtake agreements are being negotiated.

“EverGen is expanding across the country, now in three of the four largest Canadian jurisdictions for RNG. Our focus on industry consolidation and the build out of our RNG infrastructure platform is well underway as we move toward the potential to produce over 1,000,000 GJ of RNG annually,” said Chase Edgelow in a press release on the GrowTEC investment.

To that end, the company has erased its “focus on the West Coast of Canada” and replaced it with “continued growth expected across other regions in North America and beyond.”

For more information, visit the company’s website at www.EvergenInfra.com.

NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Friendable Inc. (FDBL) Announces Largest Contest to Date, with a $1,000 Cash Prize for Each Winner in Five Music Genres

 

  • Friendable announces the “Song of the Summer” contest through Artist Republik, with artist submissions accepted through July 31, 2022
  • One winner in each genre – Hip Hop/Rap, Rock/Punk/Metal, Latin, EDM, and Pop – will be voted on by fans to win $1,000, a total of $5,000 across all genres
  • Friendable’s acquisition of Artist Republik and FeaturedX in January 2022 has expanded the Fan Pass Live offering to create a 360-degree suite of services for independent artists to produce, distribute, and market their music without label control

Friendable (OTC: FDBL), a mobile technology and marketing company, recently announced its “Song of the Summer” contest and artist promotion through its Fan Pass Live branded Artist Republik offering. Friendable is promoting the contest to the 120,000 registered music artists within its database and across social media channels, blogs, and related media outlets for exposure to artists and fans. The Company has received an immediate, positive response to the contest, with artist entries pouring in since the contest opened last week. Registration for the contest will remain open until July 31, 2022, and fan voting begins in August to determine each of the five winners, one per genre (https://ibn.fm/iTpOq).

The “Song of the Summer” contest allows artists to submit a song in five genres – Hip Hop/Rap, Rock/Punk/Metal, Latin, EDM, and Pop. A winner will be chosen by the fans, with the winner of each genre to receive $1,000. A total of $5,000 will be awarded to the five winners across the five different genres. The winners of each genre will be crowned once voting ends. For more about the “Song of the Summer” contest, visit https://artistrepublik.com/sots.

“This contest has been a highly sought after and anticipated promotion since it began with the former Artist Republik management team. Now that our team has taken over, it’s our pleasure to have revamped the contest with new technology, tracking, leader boards, promotion, and tools for each artist to promote themselves to fans to attract the most votes to their ‘Song of the Summer’ submission,” Friendable Robert A. Rositano, Jr., said. 

Rositano explained that in previous years the promotion garnered over 10,000 sign-ups, but artists have never had the opportunity to engage with their fans beyond the vote, and that is something Friendable’s 360-degree offering is going to change. “With our 360 offering including Artist Republik services, FeaturedX, and Fan Pass Live, each artist can continue monetizing from the fan engagement created by our promotion, further gathering more content, traffic, and revenue for the Company overall,” he added. 

Friendable announced its acquisition of Artist Republik and FeaturedX in January 2022, bringing together a 360-degree suite of services for artists, completing its flagship offering, the Fan Pass Live artist platform. Artists can now sign up for the Fan Pass Live artist platform and benefit from music production, distribution, and marketing services without the control of music labels pulling the strings or eating up revenue. 

The combination of Fan Pass Live, Artist Republik, and FeaturedX offers artists an assortment of resources and benefits, including:

  • Music Distribution and Management
  • Music Production Assistance
  • Press Release and Instagram Promotion
  • Digital Storefront Activation
  • Artist Marketplace for Collaborations
  • Merchandise, Logo, and Promotional Design Support
  • Virtual Concert Booking and Ticketing Mobile Streaming Services
  • Live Streaming Support
  • Revenue from Fan Tips, Monthly Artist Contests, Merchandise, and Ticket Sales
  • Access to Fan Data and Performance Analytics
  • Monthly Artist Contests
  • NFT Development and Metaverse Performances – Coming Soon

The 360-degree suite of Fan Pass Live, Artist Republik, and FeaturedX promotes being an independent label in an artist’s pocket, meaning there are no gatekeepers, no middleman, and artists retain 100% control of their music. With over 100,000 artists and counting trusting the Friendable line of products, independent artists now have the platform necessary to produce, distribute, and market their music without losing out on the revenue for their hard work – and they keep all rights to their music.

For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com.

NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Monday, August 1, 2022

DPCM Capital Inc. (NYSE: XPOA) and D-Wave Systems Inc. Highlight Unique Bonus Pool Structure for Up to 5 Million Shares to be Allocated Pro-Rata to Non-Redeeming DPCM Capital Stockholders

 

  • DPCM Capital stockholders have been offered an innovative bonus pool structure that incentivizes stockholders and reduces their cost basis per share by as much as 31%
  • The bonus pool is highlighted ahead of the July 29, 2022 redemption deadline to incentivize ongoing retention and long-term investment in D-Wave by DPCM Capital stockholders

DPCM Capital (NYSE: XPOA), a special purpose acquisition company, and D-Wave Systems Inc., a leader in quantum computing systems, software, and services, have highlighted an innovative bonus pool structure for DCPM Capital stockholders in advance of the deadline for redemption at 5:00 p.m. EDT on July 29, 2022. Upon closing of the proposed business combination between DPCM Capital and D-Wave, a new company, D-Wave Quantum Inc., will become the parent company of D-Wave Systems and DPCM, and is expected to trade on the NYSE under the ticker symbol ‘QBTS’ (https://ibn.fm/tKya9).

To incentivize ongoing retention and long-term investment, the bonus pool proposed by DPCM and D-Wave of up to 5 million shares of common stock of D-Wave Quantum Inc. will be allocated to non-redeeming public stockholders of DPCM Capital on a pro-rata basis. The incentivized structure effectively reduces investors’ cost basis per share by as much as 31%. A similar bonus pool of up to 1.8 million shares has been established for Private Investment in Public Equity (“PIPE”) investors to ensure the same effective cost for PIPE investors as for the public stockholders in DPCM Capital.

“We are living in an unprecedented time and facing an unpredictable market. Because of this volatility, and because of our heritage of complex problem solving (we commercialized the first quantum computer when no one thought it was possible), we thought we’d take a slightly different and more direct approach,” D-Wave CEO Alan Baratz said. “This bonus pool enables D-Wave to provide DPCM Capital’s stockholders with an innovative economic incentive that is designed to minimize redemptions and further facilitate long-term value creation.”

The special meeting of the stockholders will take place at 10:00 a.m. EDT on August 2, 2022, to approve, among other things, the business combination of DPCM and D-Wave. Those stockholders of record as of June 10, 2022, will be entitled to receive notice of, and to vote at, this special meeting.

As a leader in quantum computing systems, software, and services, D-Wave is well-known for its annealing system, which rapidly identifies minimums in problems that span many variables and options. Where traditional computers and computation systems fall short, D-Wave’s quantum annealing system can solve them. The company’s commercial products include:

  • Advantage(TM) – a fifth-generation quantum computer
  • Leap(TM) – a quantum cloud service
  • Launch(TM) – a quantum computing onboarding service
  • Ocean(TM) – a full suite of open-source programming tools

D-Wave recently finalized agreements with two top financial institutions to use quantum computing services: Mastercard (NYSE: MA) and CaixaBank. Through these strategic collaborations, D-Wave expects to deliver more value and enhance the overall customer experience for financial institutions.

Through its full-stack, cross-platform approach, alongside its go-to-market strategy, technical capabilities and product vision, D-Wave is positioned to capture a significant portion of the quantum total addressable market. Boston Consulting Group notes that the quantum computing total addressable market (“TAM”) could reach up to $5 billion in the near term and between $450 and $850 billion by 2040, with combinatorial optimization problems, which are best suited for annealing systems, representing approximately 24% to 26% of the TAM, which translates to $500 million to $1.2 billion in the near term, potentially growing to $112 billion to $212 billion longer term. The 20% of this TAM that is expected to be available to quantum hardware, software and service providers such as D-Wave is $100 million to $250 million in the near term, potentially growing to $22 billion to $42 billion longer term.

For more information, visit the D-Wave Systems website at www.DWaveSys.com.

NOTE TO INVESTORS: The latest news and updates relating to XPOA are available in the company’s newsroom at https://ibn.fm/XPOA

Important Information About the Business Combination between D-Wave and DPCM Capital and Where to Find It:

A full description of the terms of the Business Combination between D-Wave and DPCM Capital is provided in the Registration Statement, to be issued in connection with the Business Combination and the Proxy Statement with respect to the stockholder meeting of DPCM Capital to vote on the Business Combination. D-Wave Quantum Inc. and DPCM Capital urge investors, stockholders, and other interested persons to read the Proxy Statement, as well as other documents filed with the SEC, because these documents contain important information about D-Wave Quantum Inc., DPCM Capital, D-Wave, and the Business Combination. DPCM Capital commenced mailing the Proxy Statement to its stockholders on or about July 13, 2022 in connection with the Business Combination. Stockholders also may obtain a copy of the Registration Statement, as amended—including the Proxy Statement and other documents filed with the SEC without charge—by directing a request to: D-Wave Quantum Inc., 3033 Beta Avenue, Burnaby, BC V5G 4M9 Canada, or via email at shareholdercomm@dwavesys.com and DPCM Capital, 382 NE 191 Street, #24148, Miami, Florida 33179, or via email at mward@hstrategies.com. The Proxy Statement included in the Registration Statement, can also be obtained, without charge, at the SEC’s website (www.sec.gov).

Forward-Looking Statements

This communication contains forward-looking statements that are based on beliefs and assumptions, and on information currently available. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. We caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, which are subject to a number of risks. Forward-looking statements in this communication include, but are not limited to, statements regarding the Business Combination, including the timing and structure of the Business Combination; statements regarding the timing of the Special Meeting and the bonus pool being made available to DPCM Capital stockholders; the listing of D-Wave Quantum Inc.’s shares; the amount and use of the proceeds of the Business Combination; the combined company’s future growth and innovations; the increased adoption of quantum computing solutions and expansion of related market opportunities and use cases; the total addressable market for quantum computing; the collaboration with CaixaBank and Mastercard; the consummation of private placements conducted in connection with the Business Combination; the initial market capitalization of D-Wave Quantum Inc.; the amount of funds available in DPCM Capital’s trust account as a result of stockholder redemptions or otherwise; and the anticipated benefits of the Business Combination. We cannot assure you that the forward-looking statements in this communication will prove to be accurate. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including risks relating to general economic conditions, risks relating to the immaturity of the quantum computing market and other risks, uncertainties and factors set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in DPCM Capital’s Annual Report on Form 10-K filed with the SEC on March 15, 2022, and in the Proxy Statement filed by D-Wave Quantum Inc. in connection with the Business Combination, and other filings with the SEC. Furthermore, if the forward-looking statements prove to be inaccurate, the inaccuracy may be material. In addition, you are cautioned that past performance may not be indicative of future results. In light of the significant uncertainties in these forward-looking statements, you should not rely on these statements in making an investment decision or regard these statements as a representation or warranty by any person that D-Wave Quantum Inc., DPCM Capital, or D-Wave will achieve our objectives and plans in any specified time frame, or at all. The forward-looking statements in this communication represent our views as of the date of this communication. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this communication.

No Offer or Solicitation

This communication is for informational purposes only and does not constitute an offer or invitation for the sale or purchase of securities, assets, or the business described herein or a commitment to D-Wave Quantum Inc., DPCM Capital, or D-Wave, nor is it a solicitation of any vote, consent, or approval in any jurisdiction pursuant to or in connection with the Business Combination or otherwise, nor shall there be any sale, issuance, or transfer of securities in any jurisdiction in contravention of applicable law.

Participants in Solicitation

D-Wave Quantum Inc., DPCM Capital, and D-Wave, and their respective directors and executive officers, may be deemed participants in the solicitation of proxies of DPCM Capital’s stockholders in respect of the Business Combination. Information about the directors and executive officers of DPCM Capital is set forth in DPCM Capital’s filings with the SEC. Information about the directors and executive officers of D-Wave Quantum Inc. and more detailed information regarding the identity of all potential participants, and their direct and indirect interests by security holdings or otherwise, is set forth in the Proxy Statement. Additional information regarding the identity of all potential participants in the solicitation of proxies to DPCM Capital’s stockholders in connection with the Business Combination and other matters to be voted upon at the Special Meeting, and their direct and indirect interests, by security holdings or otherwise, is included in the Proxy Statement.

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – QSAM Biosciences Inc. (QSAM) Targeting Significant Unmet Medical Need with CycloSam(R)

 QSAM Biosciences (OTCQB: QSAM) is a company developing a new class of drugs called radiopharmaceuticals that deliver radiation therapy directly and specifically to cancer cells. The company’s lead drug candidate, CycloSam(R), is a clinical-stage bone-seeking radiopharmaceutical designed to deliver targeted radiation safely and precisely to tumors in the bone. “QSAM is leading the charge to evaluate a new treatment for bone cancer and other related, underserved diseases. The company’s pioneering efforts are evident as the first patient has completed treatment in the company’s clinical trial designed to study the effect of its proprietary radiopharmaceutical technology: CycloSam(R),” a recent article reads. “This is an important milestone for QSAM,” said the company’s co-founder and CEO Douglas R. Baum. “Successfully treating patients with primary or secondary bone cancer remains an area of significant unmet medical need and a goal for CycloSam(R).”

To view the full article, visit https://ibn.fm/A2btJ

About QSAM Biosciences Inc.

QSAM Biosciences is developing next-generation nuclear medicines for the treatment of cancer and related diseases. QSAM’s initial technology, CycloSam(R) (Samarium-153 DOTMP), is a clinical-stage bone-targeting radiopharmaceutical developed by IsoTherapeutics Group LLC, pioneers in the nuclear medicine space who also developed the FDA-approved Quadramet(R) (Samarium-153 EDTMP) radiopharmaceutical product, which is indicated for pain palliation. QSAM is led by an experienced executive team and board of directors that have completed numerous FDA approvals and multiple successful biotech exits. CycloSam has demonstrated preliminary safety and efficacy in animal studies and a single patient FDA-cleared human trial performed in 2020 at the Cleveland Clinic. This nuclear technology uses low specific activity Samarium-153 (resulting in far less long-lived europium impurities) and DOTMP, a chelator believed to reduce or eliminate off-target migration and targets sites of high bone turnover, making it, in management’s opinion, an ideal agent to treat primary and secondary bone cancers. Since CycloSam delivers targeted radiation selectively to the skeletal system and to bone tumors, it is also believed to be a great candidate for effectiveness trials in bone marrow ablation as preconditioning for bone marrow transplantation, as well as in procedures to reduce external beam radiation to bone tumors. This multi-patented drug candidate utilizes a radioisotope previously approved by the FDA combined with a novel chelant, DOTMP, that has demonstrated preliminary increased efficacy and decreased side effects in animal models and veterinary treatment of bone cancer in dogs. Further, CycloSam utilizes a streamlined, just-in-time manufacturing process that is already in place. Given these factors, management believes there is a strong pathway to commercialization for CycloSam. For more information, visit the company’s website at https://QSAMBio.com.

NOTE TO INVESTORS: The latest news and updates relating to QSAM are available in the company’s newsroom at http://ibn.fm/QSAM

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php